Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HDFC Bank Limited Common Stock (HDB) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance

HDFC Bank Limited Common StockTrade
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade

Price performance (Past 24H)

Key statistics

HDFC Bank Limited Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? HDFC Bank Limited Common Stock trades at $22.27 (market cap $110.31B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.73 (market cap $58.74B). The key difference: HDFC Bank Limited Common Stock is the larger of the two by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold HDFC Bank Limited Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.

HDBTAK
Market Cap
$110.31B$58.74B
Volume
13,548,2043,110,994
Sector
FinancialsHealth
52-Week High
$37.18$19.05
52-Week Low
$21.84$13.23
Typical Hold Time
1 Days1 Days
Enterprise Value
$14.19T$86.65B
Dividend Yield
1.86%3.33%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About HDFC Bank Limited Common Stock

HDFC Bank provides retail, wholesale, and treasury banking services in India. Its offerings include deposits, lending, payments, trade finance, and financial services for individuals and businesses.

Read more on HDB →

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →